ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Barouch 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Dan Barouch 18-December-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen ✔

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
NIH ✔

Gates Foundation ✔

Henry Jackson Foundation ✔

Barouch 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
DARPA ✔

amfAR ✔

Gilead ✔

MRC ✔

Ragon Institute ✔

MassCPR ✔

Sanofi ✔

Legend ✔

Zentalis ✔

Alkermes ✔

Intima ✔

SQZ Biotech ✔ consulting

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Patent? Pending? Issued? Licensed? Royalties? Licensee? Comments

COVID-19 vaccine patents Janssen no pre-market payments or

62/969,008 ✔ royalties
62/994,630

Barouch 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Barouch reports grants from Janssen, during the conduct of the study; grants from NIH, grants from Gates Foundation,
grants from Henry Jackson Foundation, grants from DARPA, grants from amfAR, grants from Gilead, grants from MRC,
grants from Ragon Institute, grants from MassCPR, grants from Sanofi, grants from Legend, grants from Zentalis, grants
from Alkermes, grants from Intima, personal fees from SQZ Biotech, outside the submitted work; In addition, Dr. Barouch
has a patent COVID-19 vaccine patents
62/969,008
62/994,630 pending to Janssen.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Barouch 4
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Berghmans 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Pieter-Jan Berghmans 06-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? Yes ✔ No

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Berghmans 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Berghmans has nothing to disclose.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Berghmans 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Cohen 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Kristen Cohen 09-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines & Prevention ✔ Fee for service collaboration

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines & Prevention ✔ Fee for service collaboration

Cohen 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Cohen reports grants from Janssen Vaccines & Prevention, during the conduct of the study; grants from Janssen
Vaccines & Prevention, outside the submitted work; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Cohen 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Cormier 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Emmanuel Cormier 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted Shares, stock/
✔ ✔
company options

Cormier 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Cormier reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study; personal
fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Cormier 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

de Groot 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Anne Marit de Groot 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA Funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee
✔
company

de Groot 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. de Groot reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study;
personal fees from Janssen Vaccines and Prevention, a JnJ company, utside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

de Groot 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

de Hoon 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Jan de Hoon 07-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Research & Development Clinical trial sponsored by Janssen
✔
R&D

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

de Hoon 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. de Hoon reports other from Janssen Research & Development, during the conduct of the study; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

de Hoon 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

De Rosa 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Stephen De Rosa 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
NIH/NIAID ✔

Janssen Vaccines & Prevention B.V. Contract to Fred Hutchinson Cancer

✔ Research Center to perform flow
cytometry testing

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

De Rosa 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. De Rosa reports grants from NIH/NIAID, other from Janssen Vaccines & Prevention B.V., during the conduct of the
study; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

De Rosa 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Douoguih 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Macaya Douoguih 16-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a J&J Employee, restricted shares, stock
✔ ✔
company

Douoguih 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Douoguih reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study;
personal fees and other from Janssen Vaccines and Prevention, a J&J company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Douoguih 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Heerwegh 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Dirk Heerwegh 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock
✔ ✔
company

Heerwegh 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Heerwegh reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study;
personal fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Heerwegh 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Hendriks 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Jenny Hendriks 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock
✔ ✔
company

Hendriks 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Hendriks reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study;
personal fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Hendriks 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Kimmel 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Murray Kimmel 09-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitmaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? Yes ✔ No

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Kimmel 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Kimmel has nothing to disclose.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Kimmel 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Le Gars 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Mathieu Le Gars 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee
✔
company

Le Gars 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Le Gars reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study; personal
fees from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Le Gars 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Leroux-Roels 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Isabel Leroux-Roels 09-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Jerald Sadoff
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Johnson and Johnson J&J paid the Ghent University
✔ Hospital to perform the clinical trial
described in this manuscript .

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Leroux-Roels 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Leroux-Roels reports grants from Johnson and Johnson during the conduct of the study.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Leroux-Roels 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

McElrath 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

M Juliana McElrath 06-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention ✔ contract to perform T cell assays

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

McElrath 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. McElrath reports grants from Janssen Vaccines and Prevention during the conduct of the study.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

McElrath 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Sadoff 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Jerald Sadoff 09-December-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
BARDA ✔ Co-funding for R&D Program

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock JnJ
✔ ✔
company

Sadoff 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Sadoff reports grants from BARDA, during the conduct of the study; personal fees and other from Janssen Vaccines and
Prevention, a JnJ company, outside the submitted work; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Sadoff 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Scheper 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Gert Scheper 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock
✔ ✔
company

Scheper 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Scheper reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study; personal
fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Scheper 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Schuitemaker 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Hanneke Schuitemaker 12-October-2020

4. Are you the corresponding author? ✔ Yes No

5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
BARDA ✔ Co-funding for R&D program

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock JnJ
✔ ✔
company

Schuitemaker 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Schuitemaker reports grants from BARDA, during the conduct of the study; personal fees and other from Janssen
Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Schuitemaker 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Shukarev 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Georgi Shukarev 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock
✔ ✔
company

Shukarev 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Shukarev reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study;
personal fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Shukarev 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Smith 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

William Smith 08-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? Yes ✔ No

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Alliance for Multispecialty Research, LLC Dr Smith is an employee of Alliance
✔ for Multispecialty Research, a clinical
research company.

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Smith 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Smith reports personal fees from Alliance for Multispecialty Research, LLC, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Smith 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Stephenson 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Kathryn Stephenson 07-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? Yes ✔ No

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Stephenson 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Stephenson has nothing to disclose.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Stephenson 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Stoop 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Jeroen Stoop 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock
✔ ✔
company

Stoop 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Stoop reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study; personal
fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work; .

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Stoop 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Struyf 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Frank Struyf 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

2034201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares
✔ ✔
company

Struyf 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Struyf reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study; personal
fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Struyf 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Tete 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Sarah Tete 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee
✔
company

Tete 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Tete reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study; personal
fees from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Tete 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Truyers 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Carla Truyers 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
BARDA funding of the COVID-19 vaccine
✔
project

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines, a J&J company ✔ Employee

Truyers 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Truyers reports grants from BARDA, during the conduct of the study; personal fees from Janssen Vaccines, a J&J
company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Truyers 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Van Damme 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Pierre Van Damme 06-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Research & Development, Beerse, grant obtained by the University of
Belgium ✔ Antwerp for the conduct of this
vaccine trial

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Van Damme 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
GSK Biologicals The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Pfizer The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Sanofi The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Merck The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Takeda The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Baxter The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.

Van Damme 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
CanSino China The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Themis The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Osivax The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Johnson & Johnson The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
Abbott The University of Antwerp obtains
grants from several SME and vaccine
manufacturers for the conduct of
vaccine trials for which P Van Damme
✔
is the investigator and for the
support of the Viral Hepatitis
Prevention Board. P Van Damme
obtains no personal remuneration.
The Bill & Melinda Gates Foundation The University of Antwerp obtains
grants from foundations, EU and
✔ Government for the conduct of trials
and vaccine research for which P Van
Damme is the (principal) investigator
PATH The University of Antwerp obtains
grants from foundations, EU and
✔ Government for the conduct of trials
and vaccine research for which P Van
Damme is the (principal) investigator

Van Damme 4
ICMJE Form for Disclosure of Potential Conflicts of Interest

Flemish Government The University of Antwerp obtains

grants from foundations, EU and
✔ Government for the conduct of trials
and vaccine research for which P Van
Damme is the (principal) investigator
European Union The University of Antwerp obtains
grants from foundations, EU and
✔ Government for the conduct of trials
and vaccine research for which P Van
Damme is the (principal) investigator

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Van Damme reports grants from Janssen Research & Development, Beerse, Belgium , during the conduct of the study;
grants from GSK Biologicals, grants from Pfizer, grants from Sanofi, grants from Merck, grants from Takeda, grants from
Baxter, grants from CanSino China, grants from Themis, grants from Osivax, grants from Johnson & Johnson, grants from
Abbott, grants from The Bill & Melinda Gates Foundation, grants from PATH, grants from Flemish Government, grants from
European Union, outside the submitted work.

Van Damme 5
ICMJE Form for Disclosure of Potential Conflicts of Interest

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Van Damme 6
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Van Damme 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Wim Van Damme 13-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
BARDA ✔

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Pharmaceutica NV ✔ employee

Van Damme 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Van Damme reports grants from BARDA during the conduct of the study; personal fees from Janssen Pharmaceutica NV,
outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Van Damme 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Van Hoof 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Johan Van Hoof 07-December-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below. If you have more than one entity press the "ADD" button to add a row.
Excess rows can be removed by pressing the "X" button.

Name of Institution/Company Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ BARDA funding
✔
company

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? ✔ Yes No
If yes, please fill out the appropriate information below.

Name of Entity Grant? Personal Non-Financial Other ? Comments

Fees? Support?
Janssen Vaccines and Prevention, a JnJ Employee, restricted shares, stock
✔ ✔
company

Van Hoof 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Van Hoof reports grants from Janssen Vaccines and Prevention, a JnJ company, during the conduct of the study;
personal fees and other from Janssen Vaccines and Prevention, a JnJ company, outside the submitted work.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Van Hoof 3
ICMJE Form for Disclosure of Potential Conflicts of Interest

Instructions

The purpose of this form is to provide readers of your manuscript with information about your other interests that could
influence how they receive and understand your work. The form is designed to be completed electronically and stored
electronically. It contains programming that allows appropriate data display. Each author should submit a separate
form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts.

1. Identifying information.
2. The work under consideration for publication.
This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the
work itself, from the initial conception and planning to the present. The requested information is about resources that you received,
either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work
without receiving any financial support from any third party -- that is, the work was supported by funds from the same institution that
pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds
from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check
"Yes".

3. Relevant financial activities outside the submitted work.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that
give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity
that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor
(EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer
in general, not just in the area of EGFR or lung cancer.
Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to
submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the
entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work
should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.
For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be
perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be
perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or
academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved
and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

4. Intellectual Property.
This section asks about patents and copyrights, whether pending, issued, licensed and/or receiving royalties.

5. Relationships not covered above.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work.

Definitions.
Entity: government agency, foundation, commercial sponsor,
academic institution, etc.
Grant: A grant from an entity, generally [but not always] paid to your
organization
Personal Fees: Monies paid to you for services rendered, generally
honoraria, royalties, or fees for consulting , lectures, speakers bureaus,
expert testimony, employment, or other affiliations
Non-Financial Support: Examples include drugs/equipment
supplied by the entity, travel paid by the entity, writing assistance,
administrative support, etc.
Other: Anything not covered under the previous three boxes
Pending: The patent has been filed but not issued
Issued: The patent has been issued by the agency
Licensed: The patent has been licensed to an entity, whether
earning royalties or not
Royalties: Funds are coming in to you or your institution due to your
patent

Yu 1
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 1. Identifying Information

1. Given Name (First Name) 2. Surname (Last Name) 3. Date

Jingyou Yu 12-October-2020

4. Are you the corresponding author? Yes ✔ No Corresponding Author’s Name

Hanneke Schuitemaker
5. Manuscript Title
Interim Results of a Phase 1/2a Trial with the Ad26.COV2.S Covid-19 Vaccine

6. Manuscript Identifying Number (if you know it)

20-34201

Section 2. The Work Under Consideration for Publication

Did you or your institution at any time receive payment or services from a third party (government, commercial, private foundation, etc.) for
any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation,
statistical analysis, etc.)?
Are there any relevant conflicts of interest? Yes ✔ No

Section 3. Relevant financial activities outside the submitted work.

Place a check in the appropriate boxes in the table to indicate whether you have financial relationships (regardless of amount
of compensation) with entities as described in the instructions. Use one line for each entity; add as many lines as you need by
clicking the "Add +" box. You should report relationships that were present during the 36 months prior to publication.
Are there any relevant conflicts of interest? Yes ✔ No

Section 4. Intellectual Property -- Patents & Copyrights

Do you have any patents, whether planned, pending or issued, broadly relevant to the work? Yes ✔ No

Yu 2
ICMJE Form for Disclosure of Potential Conflicts of Interest

Section 5. Relationships not covered above

Are there other relationships or activities that readers could perceive to have influenced, or that give the appearance of
potentially influencing, what you wrote in the submitted work?

Yes, the following relationships/conditions/circumstances are present (explain below):

✔ No other relationships/conditions/circumstances that present a potential conflict of interest

At the time of manuscript acceptance, journals will ask authors to confirm and, if necessary, update their disclosure statements.
On occasion, journals may ask authors to disclose further information about reported relationships.

Section 6. Disclosure Statement

Based on the above disclosures, this form will automatically generate a disclosure statement, which will appear in the box
below.

Dr. Yu has nothing to disclose.

Evaluation and Feedback

Please visit http://www.icmje.org/cgi-bin/feedback to provide feedback on your experience with completing this form.

Yu 3